Literature DB >> 21221735

Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application.

Xi Liu1, Lei Lei, Jing-Wen Hou, Mu-Fei Tang, Sheng-Rong Guo, Zhong-Min Wang, Ke-Min Chen.   

Abstract

The ethylene vinyl acetate copolymer (EVA)/Poly (lactic acid) (PLA) blend and EVA/Poly (ethylene glycol) (PEG) blend were applied as the drug carrier materials for a bi-layer drug-loaded stent coating film, which consisted of a paclitaxel (PTX)-loaded layer and a drug-free EVA layer. The changes of weight and appearance of the drug-free polymeric blend films with increasing time were examined by X-ray diffraction analysis (XRD), gel permeation chromatography (GPC) tests and scanning electronic microscopy (SEM), and the results showed the degradation of PLA and the leaching of PEG from the films. The effects of PLA, PEG and drug contents on in vitro drug release were investigated, and the results demonstrated that the addition of PLA promoted the drug release while the addition of PEG almost did not. Franz cells diffusion test results indicated that the bi-layer structure successfully endowed the stent coating with the release of drug in a unidirectional fashion. The release profiles of films incorporated PTX and the mechanical performance of the film could be customized by readily adjusting the contents of the blend components. Therefore, the polymeric blends could be useful drug carrier materials for drug-loaded stent coating capable of releasing drug in a highly tunable manner.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221735     DOI: 10.1007/s10856-010-4213-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  23 in total

1.  Poly(ethylene carbonate): a thermoelastic and biodegradable biomaterial for drug eluting stent coatings?

Authors:  F Unger; U Westedt; P Hanefeld; R Wombacher; S Zimmermann; A Greiner; M Ausborn; T Kissel
Journal:  J Control Release       Date:  2006-11-11       Impact factor: 9.776

2.  Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions.

Authors:  John K Jackson; Kevin C Skinner; Laurette Burgess; Tyler Sun; William L Hunter; Helen M Burt
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

Review 3.  Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS.

Authors:  Emerson C Perin
Journal:  Rev Cardiovasc Med       Date:  2005       Impact factor: 2.930

4.  Physicochemical characteristics of quinupramine in the EVA matrix.

Authors:  Cheong-Weon Cho; Jun-Shik Choi; Sang-Chul Shin
Journal:  Int J Pharm       Date:  2006-06-13       Impact factor: 5.875

5.  In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery.

Authors:  Zhenghong Xu; Wangwen Gu; Jun Huang; Hong Sui; Zhaohui Zhou; Yongxin Yang; Zhou Yan; Yaping Li
Journal:  Int J Pharm       Date:  2004-12-10       Impact factor: 5.875

6.  In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.

Authors:  Liang Cheng; Lei Lei; Shengrong Guo
Journal:  Int J Pharm       Date:  2009-12-18       Impact factor: 5.875

7.  A type of esophageal stent coating composed of one 5-fluorouracil-containing EVA layer and one drug-free protective layer: in vitro release, permeation and mechanical properties.

Authors:  Qinghai Guo; Shengrong Guo; Zhongmin Wang
Journal:  J Control Release       Date:  2007-01-12       Impact factor: 9.776

8.  X-ray diffraction from paclitaxel-loaded zwitterionic and cationic model membranes.

Authors:  Leide P Cavalcanti; Oleg Konovalov; Heinrich Haas
Journal:  Chem Phys Lipids       Date:  2007-06-28       Impact factor: 3.329

9.  Luminal flow patterns dictate arterial drug deposition in stent-based delivery.

Authors:  Vijaya B Kolachalama; Abraham R Tzafriri; Davis Y Arifin; Elazer R Edelman
Journal:  J Control Release       Date:  2008-09-26       Impact factor: 9.776

10.  Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres.

Authors:  H Suh; B Jeong; R Rathi; S W Kim
Journal:  J Biomed Mater Res       Date:  1998-11
View more
  5 in total

1.  Novel self-assembly endows human serum albumin nanoparticles with an enhanced antitumor efficacy.

Authors:  Dawei Ding; Xiaolei Tang; Xiaoli Cao; Jinhui Wu; Ahu Yuan; Qian Qiao; Jing Pan; Yiqiao Hu
Journal:  AAPS PharmSciTech       Date:  2013-11-28       Impact factor: 3.246

2.  A biodegradable perivascular wrap for controlled, local and directed drug delivery.

Authors:  William G Sanders; Paul C Hogrebe; David W Grainger; Alfred K Cheung; Christi M Terry
Journal:  J Control Release       Date:  2012-04-27       Impact factor: 9.776

Review 3.  Burgeoning Polymer Nano Blends for Improved Controlled Drug Release: A Review.

Authors:  Saeid Maghsoudi; Bahareh Taghavi Shahraki; Navid Rabiee; Yousef Fatahi; Rassoul Dinarvand; Maryam Tavakolizadeh; Sepideh Ahmadi; Mohammad Rabiee; Mojtaba Bagherzadeh; Ali Pourjavadi; Hassan Farhadnejad; Mohammadreza Tahriri; Thomas J Webster; Lobat Tayebi
Journal:  Int J Nanomedicine       Date:  2020-06-19

4.  Stiff-Elongated Balance of PLA-Based Polymer Blends.

Authors:  Mónica Elvira Mendoza-Duarte; Iván Alziri Estrada-Moreno; Perla Elvia García-Casillas; Alejandro Vega-Rios
Journal:  Polymers (Basel)       Date:  2021-12-07       Impact factor: 4.329

5.  Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization.

Authors:  Jagadeesh G Hiremath; Nirav S Khamar; Subhash G Palavalli; Chetan G Rudani; Rajeshkumar Aitha; Prasanthkumar Mura
Journal:  Saudi Pharm J       Date:  2012-01-05       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.